HumanX: Generate Biomedicines' CEO Mike Nally describes how he sees AI going from improvements in optimization to drugging the undruggable
Mar 13, 2025
16:48
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
From the big HumanX AI conference in Las Vegas, he describes the overall path he sees AI taking in its contributions to drug development, and gives an update on Generate's programs regarding TSLP, IL13, ADCs, and more.
BiotechTV - News